By Medha Singh

(Reuters). – U.S. Stock Index Futures were marginally higher on Thursday due to easing Omicron-related worries. Dow and Dow are on track to continue record-setting runs. Now, the focus is on a weekly unemployment report that will gauge the nation’s economic health.

At 8:30 AM, the Labor Department will release weekly data on unemployment claims. Investors who want to increase their confidence in America’s economy, despite the increasing cases of COVID-19 are eagerly anticipating ET (1330 GMT).

Recent rallies in Equities were accompanied by the lowest trading volume that U.S. Stock Exchanges saw this year. This is due to growing evidence that Omicron strain causes less severe illnesses than Delta.

U.S. top infectious disease advisor, Dr. Anthony Fauci, said Wednesday that Omicron coronavirus variant cases in America are likely to spike by January.

Scott Chronert (a U.S. equity strategist) stated that Omicron’s severity was less severe and the CDC provided shorter quarantine guidelines. This is consistent with U.S. Equity Strategist Scott Chronert’s view towards incremental relief of supply chain disruptions in early-2022. Citigroup (NYSE:).

Wall Street’s principal indexes are expected to end 2013 with the sharpest 3-year increase since 1999. Attention will then shift to U.S. interest rates hikes as a result of rising costs and supply chain problems.

6.31 a.m. ET were up 20 point, or 0.5%. They were also up 4.5 points or 0.09% and up 22.5 points or 0.14%.

Biogen Inc. (NASDAQ:), which fell 6.0% in individual stock, regaining some gains from previous sessions as Samsung (KS;) BioLogics refuted a media report claiming that the South Korean drugmaker was under contract to be bought by the company.

Didi Global, China’s ride-hailing company, reported a decline of 3.4% in its third quarter revenue. This was due to a crackdown on domestic businesses.